FIELD: pharmaceutical industry; medicine.
SUBSTANCE: invention relates to the pharmaceutical industry and medicine, and it is a pharmaceutical composition based on an aqua-complex of titanium glycerosolvate in a combination with L-arginine for the treatment of inflammatory diseases of the oral mucosa. The proposed composition has the following composition, g: tizole – 5.0, L-arginine – 1.0, PEO 400 – 47.0, PEO 1500 – 47.0.
EFFECT: composition allows for achievement of high efficiency of the treatment due to high adhesion of a drug on the oral mucosa, reduction in duration of the treatment, improvement of the life quality, and elimination of systematic side effects.
1 cl, 1 dwg, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
THERAPEUTIC AGENT FOR TREATING EXUDATIVE HYPEREMIC AND EROSIVE ULCERATIVE FORMS OF ORAL LICHEN PLANUS | 2013 |
|
RU2549498C1 |
METHOD FOR THE TREATMENT OF INFLAMMATORY PERIODONTAL DISEASES IN WOMEN IN THE MENOPAUSAL AND POSTMENOPAUSAL PERIODS | 2021 |
|
RU2763874C1 |
AGENT FOR THERAPY OF WOUND AND BURN SKIN LESIONS | 2018 |
|
RU2687485C1 |
TOOTH ELIXIR | 1995 |
|
RU2110986C1 |
METHOD FOR ADMINISTERING GASTROINTESTINAL TRACT DISEASE THERAPY | 2002 |
|
RU2245716C2 |
METHOD FOR TREATING ORAL CAVITY MUCOSA CANDIDIASIS | 1998 |
|
RU2142267C1 |
METHOD FOR TREATING CHRONIC ATROPHIC CANDIDOSIS OF ORAL MUCOSA IN PATIENTS WITH CHRONIC BILIARY-DEPENDENT PANCREATITIS | 2023 |
|
RU2812661C1 |
DENTIFRICE WATER | 1997 |
|
RU2139035C1 |
METHOD FOR LOCAL TREATMENT OF DISEASES OF ORAL MUCOSA, NASAL MUCOSA AND THAT OF PARODONTIUM TISSUES IN CASE OF INFLAMMATION | 2005 |
|
RU2302247C2 |
AGENT FOR LOCAL TREATMENT OF PERIODONTAL DISEASES | 2011 |
|
RU2491061C2 |
Authors
Dates
2023-02-06—Published
2022-08-18—Filed